Qualità delle prove 4.63/5
Punteggio di revisione su otto dimensioni rispetto alla griglia di qualità . Ogni dimensione valutata da 1 a 5.
- D1 Ancoraggio alle fonti
- 4/5
- D2 Autorità delle fonti
- 5/5
- D3 Aritmetica
- 5/5
- D4 Incertezza
- 4/5
- D5 Ambito
- 5/5
- D6 Prosa
- 5/5
- D7 Onestà sulla percezione
- 4/5
- D8 Completezza degli avvertimenti
- 5/5
Come varia il rischio
La cifra principale è una media di situazioni molto diverse. Ecco come varia la probabilità in base allo scenario o al contesto:
1 su 1.000.000
Structural floor. Ambient RF power density from cell towers at ground level is typically 1,000-10,000x below ICNIRP general public limits. No epidemiological study has found elevated cancer incidence in populations living near base stations. Multiple ecological studies (UK, Germany, Israel) have looked; none found a signal after controlling for confounders.
1 su 200.000
Placeholder reflecting the INTERPHONE top-decile finding (OR 1.40 for glioma) which the study authors attributed to bias. If the association were causal, the absolute risk increase over a baseline lifetime glioma rate of ~0.6% would be small. The FDA and WHO do not consider this finding sufficient to establish causation.
1 su 333.333
Telecom workers installing and maintaining antennas can experience near-field exposures closer to ICNIRP occupational limits. Occupational studies have not found consistent cancer elevation, but sample sizes are small. ICNIRP occupational limits are set with a 50x reduction factor below thermal thresholds.
1 su 1.000.000
mmWave radiation is absorbed in the outer layers of skin and does not penetrate to internal organs. ICNIRP 2020 guidelines explicitly cover these frequencies. No epidemiological data exists for mmWave-specific cancer risk because population-scale exposure only began in 2020. The physics of shallow penetration depth makes internal organ effects implausible at guideline-compliant levels.
La lunghezza e la tonalità della barra ordinano questi scenari tra loro, non rispetto ad altri rischi. Le probabilità esatte sono indicate accanto a ciascuno.
La base di prove per i campi elettromagnetici a radiofrequenza (RF-EMF) e il cancro è insolitamente polarizzata tra gli organismi di regolamentazione. L’IARC ha classificato i campi elettromagnetici a radiofrequenza come Gruppo 2B (“possibilmente cancerogeni”) nel 2011, basandosi principalmente sulla scoperta dello studio INTERPHONE di un rischio di glioma aumentato del 40% nel decile più alto di utilizzo cumulativo del telefono — un risultato che gli stessi autori dello studio hanno dichiarato non potersi interpretare causalmente a causa del bias di richiamo e del bias di selezione. L’odds ratio complessivo di INTERPHONE per il glioma era in realtà inferiore a 1.0 (OR 0.81), suggerendo un effetto protettivo che tutti concordano essere artefattuale. Nel frattempo, la revisione del 2020 della FDA, il WHO EMF Project, l’aggiornamento delle linee guida ICNIRP del 2020 e il 18° rapporto del UK COMARE hanno tutti concluso che il peso delle prove non supporta un legame causale tra l’esposizione a RF-EMF a livelli conformi alle linee guida e il cancro. Le linee guida ICNIRP del 2020 coprono esplicitamente le frequenze 5G fino a 300 GHz e non hanno trovato alcuna base scientifica per rivedere i limiti di esposizione del 1998, ma solo per ristrutturarne la forma per maggiore chiarezza.
Ciò che rende la paura del 5G distintiva è meno la scienza e più la sociologia. Il suo lancio ha coinciso con la pandemia di COVID-19, e le teorie del complotto che collegavano i due eventi hanno portato ad attacchi incendiari contro decine di torri cellulari nel Regno Unito, in Irlanda e nei Paesi Bassi all’inizio del 2020. La classificazione IARC 2B — concepita come etichetta di identificazione del pericolo, non di quantificazione del rischio — è stata regolarmente privata del contesto e presentata come prova che “l’OMS afferma che i telefoni cellulari causano il cancro”. Il Gruppo 2B contiene oltre 300 agenti, inclusi l’estratto di foglie intere di aloe vera, le verdure sottaceto e il talco; significa che esiste una prova limitata che non può essere ignorata, non che un rischio sia stato stabilito. La distinzione tra il quadro dell’IARC (che si chiede “questo potrebbe causare il cancro in qualsiasi scenario di esposizione?”) e la valutazione del rischio dell’OMS (che si chiede “questo causa il cancro a livelli reali?”) è sottile e sistematicamente persa nella copertura mediatica.
Per la sotto-questione del telefono in tasca, la voce sull’esposizione al calore testicolare su questo sito copre il percorso di prova più solido: effetti termici sui parametri dello sperma dovuti al calore del dispositivo, non la cancerogenesi specifica da RF. La meta-analisi di Adams del 2014 ha rilevato una riduzione della motilità dell’8.1% associata all’esposizione al telefono, ma gli intervalli di confidenza sono ampi, gli studi inclusi mescolano irradiazione in vitro con auto-segnalazioni osservazionali, e nessuno studio ha misurato gli esiti di fertilità. L’American Cancer Society non elenca gli RF-EMF tra i fattori di rischio del cancro testicolare. Per il 5G in particolare, le frequenze a onde millimetriche (24-39 GHz) vengono assorbite negli strati esterni della pelle e non penetrano negli organi interni — un vincolo fisico che rende implausibile il rischio di cancro interno a livelli di potenza conformi a ICNIRP, sebbene i dati epidemiologici su scala di popolazione a queste frequenze non esistano ancora perché la diffusione è troppo recente.
Curiosità correlate
Le torri 5G emettono radiazioni non ionizzanti a livelli migliaia di volte inferiori ai limiti di sicurezza. Non esiste un meccanismo biologico plausibile di danno. OMS, FDA e ICNIRP concordano. L'ansia e reale. Il rischio no.
Registro delle fonti
Ogni numero qui sotto è ciò che ciascuna fonte ha riportato, con la citazione testuale su cui ci siamo basati e come siamo arrivati alla nostra cifra. Clicca su qualsiasi link per verificare direttamente.
1/6 fonti verificate in modo indipendente e alla lettera rispetto alla fonte citata
-
[1] International Agency for Research on Cancer (WHO/IARC) — IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans
IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans- Statistica
RF-EMF classified as Group 2B ('possibly carcinogenic to humans') based on limited evidence of glioma in heavy mobile phone users- Estratto
“"The evidence was reviewed critically, and overall evaluated as being limited2 among users of wireless telephones for glioma and acoustic neuroma, and inadequate3 to draw conclusions for other types of cancers. The evidence from the occupational and environmental exposures mentioned above was similarly judged inadequate. The Working Group did not quantitate the risk; however, one study of past cell phone use (up to the year 2004), showed a 40% increased risk for gliomas in the highest category of heavy users (reported average: 30 minutes per day over a 10-year period)." ”
- Dati originali da
- 2011-05-31
- Consultato
- 2026-04-18 · copia archiviata
- Calcolo
- The IARC Monograph 102 Working Group evaluated RF-EMF based primarily on the Interphone study (2010) and Hardell group case-control studies. The 40% glioma increase was observed only in the highest decile of cumulative call time in Interphone, and the Interphone authors themselves cautioned that recall bias and selection bias could account for the finding. Group 2B is IARC's second-lowest risk category — it indicates limited evidence in humans and less than sufficient evidence in animals. Over 300 agents are classified 2B, including aloe vera extract, pickled vegetables, and occupational dry cleaning. The classification does not constitute a risk quantification.
-
[2] International Commission on Non-Ionizing Radiation Protection (ICNIRP) — Guidelines for Limiting Exposure to Electromagnetic Fields (100 kHz to 300 GHz)
Guidelines for Limiting Exposure to Electromagnetic Fields (100 kHz to 300 GHz)- Statistica
ICNIRP 2020 guidelines set exposure limits with large safety factors; 5G frequencies (sub-6 GHz and mmWave up to 300 GHz) remain non-ionizing and within the same framework- Estratto
“"This document presents these revised Guidelines, which provide protection for humans from exposure to EMFs from 100 kHz to 300 GHz. … Reduction factors account for biological variability in the population (e.g., age, sex), variation in baseline conditions (e.g., tissue temperature), variation in environmental factors (e.g., air temperature, humidity, clothing), dosimetric uncertainty associated with deriving exposure values, uncertainty associated with the health science, and as a conservative measure more generally." ”
- Dati originali da
- 2020-03-11
- Consultato
- 2026-04-18 · copia archiviata
- Calcolo
- ICNIRP's 2020 update reviewed the entire post-1998 literature, including studies at frequencies used by 5G (sub-6 GHz and mmWave 24-300 GHz). The guidelines explicitly cover 5G frequencies. The only confirmed health effect at these frequencies is tissue heating, and the exposure limits incorporate reduction factors of 50x (occupational) to 200x (general public) below thresholds where thermal effects begin. Actual 5G small cell power output is typically lower per base station than 4G macro towers because of the densified architecture. ICNIRP is the independent scientific body whose guidelines are adopted by most national regulators outside the US (the FCC uses IEEE standards that reach similar conclusions).
-
[3] The Lancet Oncology / INTERPHONE Study Group — Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study
Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study- Statistica
No overall increased risk of glioma or meningioma with mobile phone use; OR 0.81 (95% CI 0.70-0.94) for glioma overall; elevated OR 1.40 (95% CI 1.03-1.89) only in the highest decile of cumulative call time- Estratto
“"Overall, no increase in risk of glioma or meningioma was observed with use of mobile phones. There were suggestions of an increased risk of glioma at the highest exposure levels, but biases and error prevent a causal interpretation." ”
- Dati originali da
- 2010-05-17
- Consultato
- 2026-04-18
- Calcolo
- The INTERPHONE study is the largest case-control study of cell phone use and brain tumors, covering 13 countries with 2,708 glioma cases and 2,409 meningioma cases. The overall odds ratio for glioma was protective (0.81), which the authors attributed to participation bias. The elevated OR in the top decile (1.40) is the primary finding that drove the IARC 2B classification. The authors explicitly stated that "biases and error prevent a causal interpretation" of the top-decile result. The study covered phone use up to 2004 — before 4G, let alone 5G — and measured cumulative call time, not ambient tower exposure.
- Indipendenza
- INTERPHONE is the primary study underlying the IARC classification; the IARC source above is a downstream interpretation of this and other data. They are not independent but serve different roles — INTERPHONE provides the data, IARC provides the regulatory classification.
-
[4] US Food and Drug Administration — Scientific Evidence for Cell Phone Safety (Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer)
Scientific Evidence for Cell Phone Safety (Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer)- Statistica
FDA concluded that the weight of scientific evidence does not support the conclusion that non-ionizing RF energy from cell phones causes cancer- Estratto
“"Based on the evaluation of the currently available information, the FDA believes that the weight of the scientific evidence does not support an increase in health risks from radio frequency exposure from cell phone use at or below the radio frequency exposure limits set by the FCC." ”
- Dati originali da
- 2020-02-10
- Consultato
- 2026-06-30 · copia archiviata
- Calcolo
- The FDA's 2020 review covered epidemiological, animal, and in vitro studies published between 2008 and 2018. The review explicitly addressed the NTP (National Toxicology Program) rat study, which found some evidence of schwannoma in male rats exposed to whole-body RF at SAR levels 2-8x the human safety limit for 9 hours/day over 2 years. The FDA concluded that the NTP results were not generalizable to human cell phone use because of the vastly higher exposure levels and whole-body irradiation protocol. This is the US regulatory counterpart to ICNIRP; both bodies reached the same conclusion using different review processes.
- Indipendenza
- The FDA review is an independent US regulatory assessment. It evaluates some of the same underlying studies as IARC Monograph 102 but applies a different weight-of-evidence framework and reaches a distinct conclusion about the sufficiency of evidence for a causal link.
-
[5] World Health Organization — Electromagnetic fields and public health: mobile phones
Electromagnetic fields and public health: mobile phones- Statistica
WHO states that there is no evidence to conclude that exposure to low level electromagnetic fields is harmful to human health- Estratto
“"Despite extensive research, to date there is no evidence to conclude that exposure to low level electromagnetic fields is harmful to human health. … The user of a mobile phone encounters field levels that are much higher than any levels in the normal living environment. However, even these increased levels do not appear to generate harmful effects." ”
- Dati originali da
- 2014-10-08
- Consultato
- 2026-04-18 · copia archiviata
- Calcolo
- The WHO EMF Q&A page is the most widely cited public-health summary on mobile phone safety. It post-dates the IARC 2B classification and explicitly notes that the overall evidence does not suggest detrimental effects. WHO's own position — "no evidence to conclude that exposure to low level electromagnetic fields is harmful" — is more conservative than the Group 2B label, reflecting the difference between IARC's hazard identification framework (which asks "could this ever cause cancer under any conditions?") and WHO's risk assessment framework (which asks "does this cause cancer at real-world exposure levels?").
-
[6] Environment International (Adams, Galloway, Mondal, Esteves & Mathews, 2014) — Effect of mobile telephones on sperm quality: a systematic review and meta-analysis Verificato
Effect of mobile telephones on sperm quality: a systematic review and meta-analysisVedi tutte le 2 voci di Likelier che citano questa fonte →
- Statistica
Meta-analysis of 10 studies (1,492 samples) found mobile phone exposure associated with an 8.1% reduction in sperm motility (mean difference -8.1%, 95% CI -13.1 to -3.2)- Estratto
“"Exposure to mobile phones was associated with reduced sperm motility (mean difference -8.1% (95% CI -13.1, -3.2))." ”
- Dati originali da
- 2014-09-01
- Consultato
- 2026-07-03 · copia archiviata
- Verifica
- Estratto recuperato in modo indipendente e confermato parola per parola rispetto alla fonte citata durante il nostro audit di attendibilità.
- Calcolo
- Adams et al. (2014, Environment International) pooled 10 studies covering 1,492 semen samples, mixing in vitro irradiation experiments with observational self-report studies. This is the source for the "8.1% motility reduction" figure cited in the body's phone-in-pocket aside; the wide confidence interval (-13.1 to -3.2) is why the body describes the finding as uncertain. No study in the meta-analysis measured actual fertility or conception outcomes, only semen parameters. This source is unrelated to this entry's own cancer-risk conclusion — it backs only the tangential thermal/sperm-quality mention, which is covered in full on the separate testicular-heat-exposure entry.